Cherrydale Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$493K Buy
1,941
+1
+0.1% +$233 0.13% 48
2026
Q1
$474K Buy
1,940
+32
+2% +$7.45K 0.15% 43
2025
Q4
$395K Hold
1,908
0.12% 49
2025
Q3
$354K Buy
1,908
+344
+22% +$58.9K 0.11% 56
2025
Q2
$239K Sell
1,564
-657
-30% -$101K 0.08% 62
2025
Q1
$368K Buy
2,221
+460
+26% +$72K 0.15% 45
2024
Q4
$255K Sell
1,761
-242
-12% -$37.5K 0.1% 58
2024
Q3
$325K Buy
+2,003
New +$319K 0.13% 47
2024
Q2
Sell
-1,754
Closed -$277K 71
2024
Q1
$277K Buy
+1,754
New +$279K 0.13% 47
2023
Q4
Sell
-1,743
Closed -$271K 51
2023
Q3
$271K Sell
1,743
-223
-11% -$36.8K 0.16% 39
2023
Q2
$325K Buy
1,966
+630
+47% +$102K 0.23% 28
2023
Q1
$207K Sell
1,336
-316
-19% -$51K 0.16% 33
2022
Q4
$292K Buy
1,652
+233
+16% +$40.2K 0.24% 28
2022
Q3
$232K Buy
1,419
+28
+2% +$4.74K 0.21% 30
2022
Q2
$247K Buy
1,391
+83
+6% +$14.8K 0.23% 26
2022
Q1
$231K Buy
1,308
+52
+4% +$8.85K 0.17% 35
2021
Q4
$215K Buy
+1,256
New +$206K 0.16% 37

Other funds holding JNJ

Cherrydale Wealth Management's JNJ Position: Q2 2026 in Review

Cherrydale Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.05% in Q2 2026, buying an estimated $233 and bringing the position to 1,941 shares worth $493K. The position accounts for 0.13% of the portfolio, ranked #48.

Cherrydale Wealth Management first reported a position in JNJ in Q4 2021 and has held it in 17 quarters since. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cherrydale Wealth Management held 1,941 shares of Johnson & Johnson worth $493K as of Q2 2026.
  • Cherrydale Wealth Management bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.13% of Cherrydale Wealth Management's portfolio in Q2 2026, its #48 holding.
  • Cherrydale Wealth Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 17 quarters since.
  • 4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cherrydale Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.